6872 — TenNor Therapeutics (Suzhou) Cashflow Statement
0.000.00%
Last trade - 00:00- HK$5.01bn
- HK$4.25bn
Annual cashflow statement for TenNor Therapeutics (Suzhou), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -192 | -146 | -153 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 77.5 | 76.5 | 71.6 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 13.4 | 18.2 | -7.13 |
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -98.1 | -48.6 | -87.2 |
| Capital Expenditures | -0.513 | -0.203 | -0.453 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 70.9 | 0.018 | 2.95 |
| Sale of Business | |||
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | 70.4 | -0.185 | 2.5 |
| Financing Cash Flow Items | 2.5 | 94.6 | 198 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 4.73 | 88.5 | 171 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -23 | 39.7 | 85.9 |